Canada Communicable Disease Report
An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Update on Pediatric Invasive Pneumococcal Disease and Recommended Use of Conjugate Pneumococcal Vaccines
This statement provides an update on the epidemiology of pneumococcal disease since the introduction of Prevnar® (Wyeth Pharmaceuticals), as well as information regarding a newly authorised conjugate vaccine against pneumococcal disease, Synflorix™ (GlaxoSmithKline Inc.).